← Leaderboards
Francis G Spinale
Medical University Of South Carolina
$19,686,300
Attributed
$20,695,338
Total exposure
19
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,803,800 · 18
VA$0 · 2
By mechanism
R01$15,095,811 · 7
P20$6,316,919 · 2
R42$3,818,063 · 3
P01$433,716 · 1
M01$139,291 · 5
I01$0 · 2
Top collaborators
- Jason A Burdick5 shared
- James R Hebert3 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Michael Bradley Wallace$2,497,212
- James C Oates$6,188,464
- Carlos F Salinas$4,519,272
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailureMyocardiumExtracellular MatrixMyocardialMatrix MetalloproteinasesPeptide HydrolasesMyocardial InfarctionFamily SuidaeEventLeftFibroblastsCause Of DeathEnzymesVentricularMatrix Metalloproteinase InhibitorHeartStructureAnimal ModelDisabilityLeft Ventricular RemodelingInterstitialMicrodialysisPerformanceBiological
Grant awards (84)
The Center for Clinical and Translational Research at the University of South Carolina (CLINTRUSC)$2,187,312
P20 · FY2025 · GM · contact PI
The Center for Clinical and Translational Research at the University of South Carolina (CLINTRUSC)$721,474
P20 · FY2025 · GM · contact PI
Fibroblast targeting for myocardial repair$659,587
R01 · FY2025 · HL · contact PI
CLINTRUSC Admin Core$623,147
P20 · FY2025 · GM · contact PI
Myocardial Plasticity in Heart Failure with Preserved Ejection Fraction (HFpEF)$0
I01 · FY2025 · VA · contact PI
The Center for Clinical and Translational Research at the University of South Carolina (CLINTRUSC)$2,199,676
P20 · FY2024 · GM · contact PI
Fibroblast targeting for myocardial repair$646,395
R01 · FY2024 · HL · contact PI
CLINTRUSC Admin Core$585,310
P20 · FY2024 · GM · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2024 · VA · contact PI
Myocardial Plasticity in Heart Failure with Preserved Ejection Fraction (HFpEF)$0
I01 · FY2024 · VA · contact PI
Fibroblast targeting for myocardial repair$671,837
R01 · FY2023 · HL · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2023 · VA · contact PI
Myocardial Plasticity in Heart Failure with Preserved Ejection Fraction (HFpEF)$0
I01 · FY2023 · VA · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2022 · VA · contact PI
Myocardial Plasticity in Heart Failure with Preserved Ejection Fraction (HFpEF)$0
I01 · FY2022 · VA · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2021 · VA · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2020 · VA · contact PI
Therapeutic targeting of tissue inhibitor-4 in hypertrophy and failure$429,196
R01 · FY2019 · HL · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2019 · VA · contact PI
Proteolytic Imaging of Remodeling Myocardium$814,450
R42 · FY2018 · HL · contact PI
Therapeutic targeting of tissue inhibitor-4 in hypertrophy and failure$484,805
R01 · FY2018 · HL · contact PI
Proteolytic Imaging of Remodeling Myocardium$705,480
R42 · FY2017 · HL · contact PI
Therapeutic targeting of tissue inhibitor-4 in hypertrophy and failure$557,735
R01 · FY2017 · HL · contact PI
Therapeutic Targeting of Tissue Inhibitor-4 in Hypertrophy and Failure$26,001
R01 · FY2017 · HL · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2017 · VA · contact PI
Therapeutic targeting of tissue inhibitor-4 in hypertrophy and failure$361,745
R01 · FY2016 · HL · contact PI
Proteolytic Imaging of Remodeling Myocardium$294,131
R42 · FY2016 · HL · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2016 · VA · contact PI
Localized Targeting of Matrix Proteases Following Myocardial Infarction$484,492
R01 · FY2015 · HL · contact PI
Reversal of Myocardial Infarction by Localized Stimulation$477,473
R42 · FY2015 · HL · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2015 · VA · contact PI
Localized Targeting of Matrix Proteases Following Myocardial Infarction$521,538
R01 · FY2014 · HL · contact PI
Reversal of Myocardial Infarction by Localized Stimulation$506,573
R42 · FY2014 · HL · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2014 · VA · contact PI
Localized Targeting of Matrix Proteases Following Myocardial Infarction$455,905
R01 · FY2013 · HL · contact PI
Myocardial Protection and Matrix Proteases$322,799
R01 · FY2013 · HL · contact PI
Reversal of Myocardial Infarction by Localized Stimulation$207,628
R42 · FY2013 · HL · contact PI
Localized Targeting of Matrix Proteases Following Myocardial Infarction$40,311
R01 · FY2013 · HL · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2013 · VA · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2013 · VA · contact PI
Localized Targeting of Matrix Proteases Following Myocardial Infarction$515,830
R01 · FY2012 · HL · contact PI
Myocardial Protection and Matrix Proteases$339,075
R01 · FY2012 · HL · contact PI
Continuous monitoring of anti-fibrinolytic therapy in cardiovascular surgery$322,296
R42 · FY2012 · HL · contact PI
Continuous monitoring of anti-fibrinolytic therapy in cardiovascular surgery$372,579
R42 · FY2011 · HL · contact PI
Myocardial Protection and Matrix Proteases$368,750
R01 · FY2011 · HL · contact PI
Endothelin Receptors and Progression to Heart Failure$297,586
R01 · FY2011 · HL · contact PI
Endothelin Receptors and Progression to Heart Failure$48,356
R01 · FY2011 · HL · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2011 · VA · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2011 · VA · contact PI
Myocardial Protection and Matrix Proteases$368,750
R01 · FY2010 · HL · contact PI
Endothelin Receptors and Progression to Heart Failure$368,750
R01 · FY2010 · HL · contact PI
Collagenase Inhibition in Heart Failure$351,706
R01 · FY2010 · HL · contact PI
Continuous monitoring of anti-fibrinolytic therapy in cardiovascular surgery$117,453
R42 · FY2010 · HL · contact PI
Endothelin Receptors and Progression to Heart Failure$368,750
R01 · FY2009 · HL · contact PI
Endothelin Receptors and Progression to Heart Failure$366,378
R01 · FY2009 · HL · contact PI
Collagenase Inhibition in Heart Failure$351,697
R01 · FY2009 · HL · contact PI
Maladaptive Remodeling in Aging Myocardium$0
I01 · FY2009 · VA · contact PI
Endothelin Receptors and Progression to Heart Failure$368,750
R01 · FY2008 · HL · contact PI
Collagenase Inhibition in Heart Failure$351,688
R01 · FY2008 · HL · contact PI
Collagenase Inhibition in Heart Failure$362,879
R01 · FY2007 · HL · contact PI
HETEROGENEOUS REMODELING IN MYOCARDIAL INFARCTION$271,415
P01 · FY2007 · HL · contact PI
Endothelin Receptors and Progression to Heart Failure$207,651
R01 · FY2007 · HL · contact PI
Endothelin Receptors and Progression to Heart Failure$213,854
R01 · FY2006 · HL · contact PI
COLLAGENASE INHIBITION IN HEART FAILURE$321,750
R01 · FY2005 · HL
Protection of Myocyte Function After Cardioplegia$321,750
R01 · FY2005 · HL
Endothelin Receptors and Progression to Heart Failure$219,000
R01 · FY2005 · HL
MATRIX METALLOPROTEINASES &HEART FAILURE - LVH &NORMAL$47,170
M01 · FY2005 · RR
MATRIX METALLOPROTEINASES &HEART FAILURE POST MI$23,555
M01 · FY2005 · RR
Protection of Myocyte Function After Cardioplegia$321,750
R01 · FY2004 · HL
COLLAGENASE INHIBITION IN HEART FAILURE$321,750
R01 · FY2004 · HL
Endothelin Receptors and Progression to Heart Failure$244,000
R01 · FY2004 · HL
Matrix Metalloproteinases &Heart Failure - LVH &Normal$42,821
M01 · FY2004 · RR
Matrix Metalloproteinases &Heart Failure post MI$22,090
M01 · FY2004 · RR
Matrix Metalloproteinases &Heart Failure - Cardiomyopathy$3,655
M01 · FY2004 · RR
Protection of Myocyte Function After Cardioplegia$321,750
R01 · FY2003 · HL
COLLAGENASE INHIBITION IN HEART FAILURE$321,750
R01 · FY2003 · HL
HETEROGENEOUS REMODELING IN MYOCARDIAL INFARCTION$162,301
P01 · FY2003 · HL
COLLAGENASE INHIBITION IN HEART FAILURE$321,750
R01 · FY2002 · HL
Protection of Myocyte Function After Cardioplegia$321,750
R01 · FY2002 · HL
COLLAGENASE INHIBITION IN HEART FAILURE$312,443
R01 · FY2001 · HL
ENDOTHELIN RECEPTORS AND PROGESSION TO HEART FAILURE$176,302
R01 · FY2001 · HL
PROTECTION OF MYOCYTE FUNCTION AFTER CARDIOPLEGIA$254,160
R01 · FY2000 · HL
COLLAGENASE INHIBITION IN HEART FAILURE$231,944
R01 · FY2000 · HL
ENDOTHELIN RECEPTORS AND PROGESSION TO HEART FAILURE$171,166
R01 · FY2000 · HL